Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Brasseur, Philippe ^a   Agnamey, Patrice ^b   Gaye, Oumar ^c   Vaillant, Michel ^d,e   Taylor, Walter R J ^f,g   Olliaro, Piero L ^e,g  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^d LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTESUNATE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; SESQUITERPENE;

ADOLESCENT; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL COUNT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SENEGAL; VOMITING; ANIMAL; DRUG COMBINATION; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; MALARIA FALCIPARUM; OUTPATIENT; PARASITOLOGY; SAFETY; TREATMENT OUTCOME;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; HUMANS; MALARIA, FALCIPARUM; OUTPATIENTS; PLASMODIUM FALCIPARUM; SAFETY; SENEGAL; SESQUITERPENES; TREATMENT OUTCOME;

EID: 38449094920     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-150     Document Type: Article

References (16)

1. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. A Brockman RN Price M Van VUGT DG Heppner D Walsh P Sookto T Wimonwattrawatee S Looareesuwan NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 5 537 544 11132385
2. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. F Nosten M Van Vugt R Price C Luxemburger KL Thway A Brockman R McGready F Ter Kuile S Looareesuwan NJ White, Lancet 2000 356 9226 297 302 11071185
3. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in Kwazulu-Natal, South Africa. K Barnes DN Durrheim F Little A Jackson U Mehta E Allen SS Diamini J Tsoka B Bredenkamp DJ Mthembu, PLoS Med 2005 2 11 330
4. The consequence of reducing transmission of Plasmodium falciparum in Africa. RW Snow K Marsh, Adv Parasitol 2002 52 235 264 12521262
5. Gametocytaemia in senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine+pyrimethamine. CS Sokhna JF Trape V Robert, Parasite 2001 8 243 250 11584755
6. Plasmodium falciparum in vitro susceptibility to antimalarial drugs in Casamance (south-western senegal) during the first five years of routine use of artesunate-amodiaquine. P Agnamey P Brasseur P Eldin de Pecoulas M Vaillant P Olliaro, Antimicrob Agents Chemother 2006 50 1531 1534 16569876
7. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomized multicentre trial. M Adjuik P Agnamey A Babiker S Borrmann P Brasseur M Cisse F Cobelens S Diallo JF Faucher P Garner, Lancet 2002 359 1365 1370 11978332
8. Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal. P Agnamey P Brasseur M Cisse O Gaye J Dumoulin J Rigal WR Taylor P Olliaro, Trop Med Int Health 2005 10 9 926 933 16135201
9. Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa. P Brasseur R Guiguemde S Diallo V Guiyedi M Kombila P Ringwald P Olliaro, Trans R Soc Trop Med Hyg 1999 93 645 650 10717757
10. Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. K Stepniewska NJ White, Malar J 2006 5 127 17187673
11. Use of weight-for-age-data to optimize tablet stregth and dosing regimen for a fixed-dose artesunate-amodiaquine combination for treating falciparum malaria. WRJ Taylor DJ Terlow P Olliaro NJ White P Brasseur FO Ter Kuile, Bull World Health Organ 2006 84 956 964 17242831
12. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO, WHO/HTM/RBM/200350 2003
13. Factors contributing to anemia after uncomplicated falciparum malaria. R Price J Simpson F Nosten C Luxemburger L Hkirjaroen F Ter Kuile T Chongsuphajaisiddhi N White, Am J Trop Med Hyg 2001 65 5 614 622 11716124
14. Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. J Connor N Rafter A Rodgers, Bull World Health Organ 2004 82 12 935 939 15654408
15. Use of a pre-packadged chloroquine for the home management of presumed malaria in Malagasy children. A Ratsimbasoa M Randrianarivelojosia P Millet JL Soares L Rabarijaona B Rakotoson D Malvy D Menard, Malar J 2006 14 5 79
16. Antimalarial drug toxicity. A review. WRJ Taylor NJ White, Drug Saf 2004 27 25 61 14720085